# Doxazosin GITS (gastrointestinal therapeutic system) is an actor to consider in the control of hypertension. A narrative review

## TL;DR

This review explores doxazosin's extended-release form as a potential treatment for managing hypertension, especially in challenging cases.

## Contribution

The paper evaluates doxazosin GITS as a possible solution for hypertension management, focusing on its role in resistant cases.

## Key findings

- Doxazosin GITS may help manage hypertension despite existing treatment barriers.
- The formulation could be useful in aging populations and low-resource settings.
- It is considered for resistant hypertension cases where other therapies fail.

## Abstract

Hypertension remains a leading global cause of cardiovascular morbidity and mortality, yet blood pressure control rates remain suboptimal despite advances in antihypertensive therapy. Multiple barriers—including cost, side effects, therapeutic complexity, and physician inertia—impede effective management, particularly in aging populations and low-resource settings. This review evaluates the therapeutic role of doxazosin, particularly in its extended-release gastrointestinal therapeutic system formulation, as a potential adjunct in contemporary hypertension treatment, including resistant hypertension.